# US 2023/0410970 A1 · Methods, systems, and computer program product for pre-categorizing drug products based on characteristics thereof to reduce artificial intelligence model size used in validating the drug products

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0410970 A1
- Document ID: US20230410970A1
- Status: Published application
- Kind: A1
- Application number: 18/337,680
- Filed: 2023-06-20
- Published: 2023-12-21
- Earliest claimed: 2022-06-21
- Assignees: Parata Systems, LLC
- Applicants: Parata Systems, LLC
- Inventors: John Alfred Bugay; Todd Martin Jenkins; Abhishek Ray; Rongkai Xu
- Web page: https://patentgrep.com/patent/US20230410970A1

## CPC

- G06N 3/0464: Convolutional networks [CNN, ConvNet]
- G16H 20/10: relating to drugs or medications, e.g. for ensuring correct administration to patients
- G06N 3/09: Supervised learning
- G06N 20/00: Machine learning
- G06Q 10/10: Office automation; Time management
- G16H 70/40: relating to drugs, e.g. their side effects or intended usage
- G06N 5/01: Dynamic search techniques; Heuristics; Dynamic trees; Branch-and-bound
- G06N: COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G06Q: INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR

## Abstract

A method includes receiving information associated with a drug product, the information comprising a plurality of characteristics; filtering the information based on at least one of the plurality of characteristics to identify one of a plurality of artificial intelligence engines; and predicting, using the one of the plurality of artificial intelligence engines that was identified, a National Drug Code (NDC) for the drug product or verifying, using the one of the plurality of intelligence engines that was identified, whether the drug product matches a target drug product.

## Claims

### Claim 1

A method comprising:
receiving information associated with a drug product, the information comprising a plurality of characteristics;
filtering the information based on at least one of the plurality of characteristics to identify one of a plurality of artificial intelligence engines; and
predicting, using the one of the plurality of artificial intelligence engines that was identified, a National Drug Code (NDC) for the drug product or verifying, using the one of the plurality of intelligence engines that was identified, whether the drug product matches a target drug product.

### Claim 2 (depends on 1)

The method of claim 1, wherein the plurality of artificial intelligence engines corresponds to a plurality of value combinations of the at least one of the plurality of characteristics, respectively.

### Claim 3 (depends on 2)

The method of claim 2, wherein at least one of the plurality of characteristics is not used in filtering the information; and
wherein the at least one of the plurality of characteristics that is not used in filtering the information is used as at least one feature, respectively, in training the plurality of artificial intelligence engines.

### Claim 4 (depends on 1)

The method of claim 1, wherein the plurality of characteristics comprises size, shape, color, imprint code, or scoring.

### Claim 5 (depends on 4)

The method of claim 4, wherein the imprint code comprises an indicium of medicinal strength, an indicium of an active ingredient, and an indicium of an inactive ingredient.

### Claim 6 (depends on 4)

The method of claim 4, wherein the shape comprises round, elliptical, and other.

### Claim 7 (depends on 4)

The method of claim 4, wherein the color comprises transparent and a plurality of colors.

### Claim 8 (depends on 1)

The method of claim 1, wherein filtering the information comprises:
filtering the information based on all of the plurality of characteristics to identify the one of the plurality of artificial intelligence engines.

### Claim 9 (depends on 1)

The method of claim 1, wherein each of the plurality of artificial intelligence engines comprises a convolutional neural network.

### Claim 10 (depends on 9)

The method of claim 9, wherein the convolutional neural network comprises a plurality of convolutional layers with at least some of the plurality of convolutional layers being connected to one another via a skip connection.

### Claim 11 (depends on 1)

The method of claim 1, wherein the plurality of artificial intelligence engines corresponds to a plurality of value combinations of the at least one of the plurality of characteristics, respectively;
the method further comprising:
granting an entity access to ones of the plurality of artificial intelligence engines based on the entity distributing ones of a plurality of drug products having ones of the plurality of value combinations, respectively, that correspond to the ones of the plurality of artificial intelligence engines.

### Claim 12

A method comprising:
receiving training information associated with a drug product from a plurality of sources, the training information comprising a plurality of characteristic and a National Drug Code (NDC) the drug product;
determining whether to accept, reject, or waitlist the training information associated with the drug product based on consistency in the training information between ones of the plurality of sources; and
using the training information to train an artificial intelligence engine configured to predict NDC codes for drug products based on the plurality if characteristics when the training information is accepted.

### Claim 13 (depends on 12)

The method of claim 12, wherein determining whether to accept, reject, or waitlist the training information comprises:
accepting the training information when the training information is consistent between at least a consensus subset of ones of the plurality of sources.

### Claim 14 (depends on 13)

The method of claim 13, wherein the consensus subset comprises a minimum number X of the plurality of sources.

### Claim 15 (depends on 14)

The method of claim 14, wherein the consensus subset further comprises a minimum percentage Y of the plurality of sources.

### Claim 16 (depends on 12)

The method of claim 12, wherein determining whether to accept, reject, or waitlist the training information comprises:
using a consensus artificial intelligence engine to determine whether to accept, reject, or waitlist the training information.

### Claim 17 (depends on 16)

The method of claim 16, wherein the consensus artificial intelligence engine uses K-means clustering to determine whether to accept, reject, or waitlist the training information.

### Claim 18 (depends on 12)

The method of claim 12, further comprising:
confirming the training information with a trusted source of the training information before accepting the training information.

### Claim 19 (depends on 12)

The method of claim 12, wherein the plurality of characteristics comprises size, shape, color, imprint code, or scoring.

### Claim 20

A system, comprising:
a processor; and
a memory coupled to the processor and comprising computer readable program code embodied in the memory that is executable by the processor to perform operations comprising:
receiving information associated with a drug product, the information comprising a plurality of characteristics;
filtering the information based on at least one of the plurality of characteristics to identify one of a plurality of artificial intelligence engines; and
predicting, using the one of the plurality of artificial intelligence engines that was identified, a National Drug Code (NDC) for the drug product or verifying, using the one of the plurality of intelligence engines that was identified, whether the drug product matches a target drug product.
